Carling Ursem, MD

HS Assoc Clinical Professor

Dr. Carling Ursem is a medical oncologist with clinical expertise in the management of gastrointestinal and genitourinary malignancies. Her research focus is in prostate cancer clinical trials and specifically expanding clinical trial access to veterans.

Education
2018 - Diversity, Equity, and Inclusion Champion Training, University of California
MD, - College of Physicians and Surgeons, Columbia Univeristy
Residency, - Internal Medicine, Duke University Medical Center
BS, - Molecular Toxicology, UC Berkeley
Publications
  1. Daniel H Kwon, Marissa McPhaul, Saffanat Sumra, Carling Jade Ursem, Evan Justin Walker, Maren Theresa Scheuner, Sunny Wang, Rahul Raj Aggarwal, Franklin W. Huang, Jeffrey Belkora. Informed decision-making about germline testing among Veterans with advanced prostate cancer (APC): A mixed-methods study. Journal of Clinical Oncology 2024. PMID:


  2. Daniel H Kwon, Marissa McPhaul, Eliza Hearst, Saffanat Sumra, Carling Jade Ursem, Evan Justin Walker, Maren Theresa Scheuner, Sunny Wang, Rahul Raj Aggarwal, Franklin W. Huang, Jeffrey Belkora. Challenges in patient-centered germline testing delivery for veterans with advanced prostate cancer (APC). Journal of Clinical Oncology 2024. PMID:


  3. Howard Jinsoo Lee, Louise Christie Walter, Alexander K. Smith, Ying Shi, W. John Boscardin, Harvey Jay Cohen, Grant Richard Williams, Sandra Zeng, Carolyn J Presley, Allison Magnuson, Supriya Gupta Mohile, Surbhi Singhal, Carling Jade Ursem, Ana I. Velazquez Manana, Matthew A. Gubens, Collin M. Blakely, Claire Mulvey, Greg M. Allen, Jonathan Ostrem, Melisa L. Wong. Associations of frailty with overall survival (OS) and functional decline among older adults with non–small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/or targeted therapy. Journal of Clinical Oncology 2023. PMID:


  4. Wong ML, Nicosia FM, Smith AK, Walter LC, Lam V, Cohen HJ, Loh KP, Mohile SG, Ursem CJ, Schwarze ML. "You have to be sure that the patient has the full picture": Adaptation of the Best Case/Worst Case communication tool for geriatric oncology. 2022. PMID: 35123919


  5. M. Wong, F. Nicosia, A. Smith, L. Walter, V. Lam, H. Cohen, K.P. Loh, S. Mohile, C. Ursem, M. Schwarze. SIOG2021-0067* “You have to be sure that the patient has the full picture”: Adaptation of the Best Case/Worst Case (BC/WC) communication tool to geriatric oncology. Journal of geriatric oncology 2021. PMID:


  6. Wong ML, Shi Y, Smith AK, Miaskowski C, Boscardin WJ, Cohen HJ, Lam V, Mazor M, Metzger L, Presley CJ, Williams GR, Loh KP, Ursem CJ, Friedlander TW, Blakely CM, Gubens MA, Allen G, Shumay D, Walter LC. Changes in older adults' life space during lung cancer treatment: A mixed methods cohort study. 2021. PMID: 34611887


  7. Ursem C, Diaz-Ramirez LG, Boscardin J, Lee S. Changes in functional status associated with radiation for prostate cancer in older veterans. Journal of geriatric oncology 2020. PMID: 33388282


  8. Bischoff KE, Zapata C, Sedki S, Ursem C, O'Riordan DL, England AE, Thompson N, Alfaro A, Rabow MW, Atreya CE. Embedded palliative care for patients with metastatic colorectal cancer: a mixed-methods pilot study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2020. PMID: 32285263


  9. Ursem C, Zhou M, Paciorek A, Atreya CE, Ko AH, Venook A, Zhang L, Van Loon K. Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer. The oncologist 2020. PMID: 32031306


  10. Melisa L. Wong, Alexander K. Smith, Christine Miaskowski, Vivek Musinipally, Harvey Jay Cohen, Vivian Lam, Melissa Mazor, Carling Jade Ursem, Kah Poh Loh, Jamie Cohen, Dianne Shumay, Anna Ordin Levin, Niharika Dixit, Janice Grandi, Louise Christie Walter. Mixed methods comparison of functional decline during chemotherapy, immunotherapy (IO), and/or targeted therapy in older adults with non-small cell lung cancer (NSCLC). Journal of Clinical Oncology 2019. PMID:


  11. M.L. Wong, A.K. Smith, C. Miaskowski, V. Musinipally, H.J. Cohen, V. Lam, M. Mazor, C.J. Ursem, K. Loh, J.A. Cohen, D. Shumay, A.O. Levin, N. Dixit, J. Grandi, L.C. Walter. P111 “NO ENERGY, ZIP”: A MIXED METHODS COMPARISON OF FUNCTIONAL DECLINE DURING IMMUNOTHERAPY, TARGETED THERAPY, AND/OR CHEMOTHERAPY IN OLDER ADULTS WITH NON-SMALL CELL LUNG CANCER (NSCLC). Journal of geriatric oncology 2019. PMID:


  12. Melisa L. Wong, Christine Miaskowski, Alexander K. Smith, W. John Boscardin, Harvey Jay Cohen, Arti Hurria, Vivian Lam, Carling Jade Ursem, Collin Michael Blakely, Matthew A. Gubens, Thierry Marie Jahan, Caroline Elizabeth McCoach, Gregory Maners Allen, Julia Rotow, Niharika Dixit, Vivek Musinipally, Katey R. Webber, Louise Christie Walter. Prognostic factors among older adults with advanced non-small cell lung cancer (NSCLC): A multisite cohort study. Journal of Clinical Oncology 2019. PMID:


  13. Ursem C, Atreya CE, Van Loon K. Emerging treatment options for BRAF-mutant colorectal cancer. Volume 8. Gastrointestinal cancer : targets and therapy 2018. PMID: 29628780


  14. Ursem C, Venook AP. The Developing Role of Anti-Epidermal Growth Factor Receptor Agents in the Treatment of Advanced or Metastatic Colorectal Cancer. Volume 31 of Issue 11. Oncology (Williston Park, N.Y.) 2017. PMID: 29179247


  15. Ursem C, Van Loon K, Venook A. Adjuvant Therapy Trials. Volume 22 of Issue 3. Cancer journal (Sudbury, Mass.) 2016. PMID: 27341598


  16. Ursem CJ, Bosworth HB, Shelby RA, Hwang W, Anderson RT, Kimmick GG. Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income. Volume 24 of Issue 5. Journal of women's health (2002) 2015. PMID: 25884292


  17. Carling Ursem, Gretchen Genevieve Kimmick, Roger T. Anderson, Wenke Hwang, Fabian Camacho. Disparities in breast cancer presentation and treatment of older women, by insurance status. Journal of Clinical Oncology 2013. PMID:


  18. Matthews EJ, Ursem CJ, Kruhlak NL, Benz RD, Sabaté DA, Yang C, Klopman G, Contrera JF. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities. Volume 54 of Issue 1. Regulatory toxicology and pharmacology : RTP 2009. PMID: 19422098


  19. Ursem CJ, Kruhlak NL, Contrera JF, MacLaughlin PM, Benz RD, Matthews EJ. Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities. Volume 54 of Issue 1. Regulatory toxicology and pharmacology : RTP 2009. PMID: 19422096


  20. Ursem C, Evans CS, Ger KA, Richards JR, Derlet RW. Surface water quality along the Central John Muir Trail in the Sierra Nevada Mountains: coliforms and algae. Volume 10 of Issue 4. High altitude medicine & biology 2009. PMID: 20039816